MNOW — Mednow Income Statement
0.000.00%
Last trade - 00:00Consumer DefensivesSpeculativeMicro Cap
Annual income statement for Mednow, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.414 | 16.6 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 2.78 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.007 | 0.012 | 0.469 | 9.41 | 46.1 |
| Operating Profit | -0.007 | -0.012 | -0.469 | -9 | -29.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.007 | -0.012 | -0.469 | -8.95 | -30.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.007 | -0.012 | -0.469 | -8.95 | -29.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.007 | -0.012 | -0.469 | -8.95 | -29.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.007 | -0.012 | -0.469 | -8.95 | -29.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0 | -0.001 | -0.021 | -0.487 | -1.14 |
| Dividends per Share |